Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
40 pending office actions • 19 art units • 39 examiners • 0 of 40 (0%) have an AI response strategy ready • 27 patents granted in the last 365 days
Emory University has 41 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are handled by 40 distinct examiners, with GALSTER, SAMUEL LEONARD serving as the busiest examiner with 2 pending office actions. The 41 pending office actions are distributed across 19 distinct art units.
The involvement of 40 distinct examiners for the actions indicates a relationship where almost every examiner handles a single case. GALSTER, SAMUEL LEONARD is the only examiner managing more than one case, with 2 of the total pending actions. The 19 distinct art units show that the portfolio covers a variety of technical sub-sectors. With 40 distinct examiners, the university's prosecution is decentralized, requiring management of many different examiner relationships. This distribution means that no single examiner or art unit has a dominant influence over the 41 total pending actions.
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (10%) |
| §103 only | 7 (18%) |
| §102 only | 2 (5%) |
| §112 only | 3 (8%) |
| Double-patenting + other | 6 (15%) |
| Multi-statute (no §101) | 17 (42%) |
| No statute on record | 1 (2%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GALSTER, SAMUEL LEONARD | 2 | 50.9% | +43.2% |
| MATTHEWS, WILLIAM H | 1 | 66.7% | +21.6% |
| KUO, JONATHAN T | 1 | 72.3% | +28.3% |
| NAH, JONGBONG | 1 | 75.2% | +17.5% |
| OKEKE, IZUNNA | 1 | 81.8% | +15.5% |
| RICCI, CRAIG D | 1 | 53.5% | +52.7% |
| HUYNH, VAN D | 1 | 87.0% | +13.4% |
| LUKJAN, SEBASTIAN X | 1 | 76.3% | +40.3% |
| STOCKTON, LAURA LYNNE | 1 | 75.2% | +33.7% |
| BANERJEE, KOYELI | 1 | 50.0% | +0.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18853930 | DEVICES, SYSTEMS AND METHODS FOR SECURING COMMUNICATION INTEGRITY | OKEKE, IZUNNA | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18000865 | DIRECT IN VIVO REPROGRAMMING USING TRANSCRIPTION FACTOR ETV2 GENE FOR ENDOTHELIAL CELL AND VESSEL FORMATION | KIM, TAEYOON | 49d overdue |
| 18558026 | CELL POTENCY ASSAYS, PLATFORMS, AND METHODS OF USE | ARMATO JR, DENNIS IGNATIUS | 6d |
| 18564391 | SYSTEMS AND METHODS OF USING NANOMEMBRANE ELECTRONICS | SOLOMON, JOSHUA BRENDON | 48d |
| 18993727 | RECORDING AND RECOVERY OF SIGNALS DURING STIMULATION | KUO, JONATHAN T | — |
| 18853643 | Indolium Compounds for Treating Cancer | RICCI, CRAIG D | — |
| 18901408 | MEDICAL ANALYSIS USING SPATIOTEMPORAL ANALYSIS AND TRANSFORMER-BASED MODELS | HUYNH, VAN D | — |
| 18819710 | SYSTEM AND METHODS FOR AUTOMATED DEEP BRAIN STIMULATION PARAMETER SELECTION VIA META-ACTIVE LEARNING OF EVOKED POTENTIALS | LUKJAN, SEBASTIAN X | — |
| 18742659 | RNA-Dependent RNA Polymerase Inhibitory Compounds, Uses in Managing Viral Infections, and Pharmaceutical Compositions | BANERJEE, KOYELI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19380466 | 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | GALSTER, SAMUEL LEONARD | — |
| 19304178 | Cardiac Valve Leaflet Enhancer Devices and Systems | MATTHEWS, WILLIAM H | — |
| 18993727 | RECORDING AND RECOVERY OF SIGNALS DURING STIMULATION | KUO, JONATHAN T | — |
| 18961390 | Systems and Methods for Correcting Intravoxel and/or Voxel Inhomogeneity | NAH, JONGBONG | — |
| 18853930 | DEVICES, SYSTEMS AND METHODS FOR SECURING COMMUNICATION INTEGRITY | OKEKE, IZUNNA | — |
| 18853643 | Indolium Compounds for Treating Cancer | RICCI, CRAIG D | — |
| 18901408 | MEDICAL ANALYSIS USING SPATIOTEMPORAL ANALYSIS AND TRANSFORMER-BASED MODELS | HUYNH, VAN D | — |
| 18819710 | SYSTEM AND METHODS FOR AUTOMATED DEEP BRAIN STIMULATION PARAMETER SELECTION VIA META-ACTIVE LEARNING OF EVOKED POTENTIALS | LUKJAN, SEBASTIAN X | — |
| Art Unit | Apps |
|---|---|
| 1693 | 3 |
| 3774 | 2 |
| 3792 | 2 |
| 1626 | 2 |
| 1631 | 2 |
| 2408 | 1 |
| 3791 | 1 |
| 1634 | 1 |
| 1691 | 1 |
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19380466 | 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | GALSTER, SAMUEL LEONARD | 1693 | §103 | Final Rejection | — | Pending | Nov 05, 2025 |
| 19304178 | Cardiac Valve Leaflet Enhancer Devices and Systems | MATTHEWS, WILLIAM H | 3774 | Other | Non-Final OA | — | Pending | Aug 19, 2025 |
| 18993727 | RECORDING AND RECOVERY OF SIGNALS DURING STIMULATION | KUO, JONATHAN T | — | §102§103§112 | Non-Final OA | — | Pending | Jan 13, 2025 |
| 18961390 | Systems and Methods for Correcting Intravoxel and/or Voxel Inhomogeneity | NAH, JONGBONG | — | §103 | Non-Final OA | — | Pending | Nov 26, 2024 |
| 18853930 | DEVICES, SYSTEMS AND METHODS FOR SECURING COMMUNICATION INTEGRITY | OKEKE, IZUNNA | 2408 | §102 | Non-Final OA | — | Pending | Oct 03, 2024 |
| 18853643 | Indolium Compounds for Treating Cancer | RICCI, CRAIG D | — | §102§112 | Non-Final OA | — | Pending | Oct 02, 2024 |
| 18901408 | MEDICAL ANALYSIS USING SPATIOTEMPORAL ANALYSIS AND TRANSFORMER-BASED MODELS | HUYNH, VAN D | — | §102§103 | Non-Final OA | — | Pending | Sep 30, 2024 |
| 18819710 | SYSTEM AND METHODS FOR AUTOMATED DEEP BRAIN STIMULATION PARAMETER SELECTION VIA META-ACTIVE LEARNING OF EVOKED POTENTIALS | LUKJAN, SEBASTIAN X | 3792 | §101§102§103§112 | Final Rejection | — | Pending | Aug 29, 2024 |
| 18756360 | Nucleoside Prodrugs and Uses Related Thereto | STOCKTON, LAURA LYNNE | — | §112DP | Non-Final OA | — | Pending | Jun 27, 2024 |
| 18742659 | RNA-Dependent RNA Polymerase Inhibitory Compounds, Uses in Managing Viral Infections, and Pharmaceutical Compositions | BANERJEE, KOYELI | — | §103§112 | Non-Final OA | — | Pending | Jun 13, 2024 |
| 18680912 | Methods of Producing Astrocytes or Promoting Astrocyte Development and Cell Culture Compositions Related Thereto | GRABER, JAMES J | — | §102§112 | Non-Final OA | — | Pending | May 31, 2024 |
| 18709256 | Prodrugs of Neurosteroid Analogs and Uses Thereof | JAVANMARD, SAHAR | — | §112 | Non-Final OA | — | Pending | May 10, 2024 |
| 18709395 | Prodrugs of Neurosteroid Analogs and Uses Thereof | CHAO, ALLEN | — | §112DP | Non-Final OA | — | Pending | May 10, 2024 |
| 18702922 | TREATMENT OF VIRUSES WITH ANTIVIRAL NUCLEOSIDES | CHO, DAVID H | — | §103§112DP | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18698693 | 3D AUXETIC STRUCTURES AND FABRICATION METHODS THEREOF | STEWART, ALVIN J | — | §102 | Non-Final OA | — | Pending | Apr 04, 2024 |
| 18612453 | SYSTEMS AND METHODS FOR DRIVING NEURAL ACTIVITY TO CONTROL BRAIN SIGNALING AND GENE EXPRESSION | DORNA, CARRIE R | 3791 | §112DP | Non-Final OA | — | Pending | Mar 21, 2024 |
| 18292483 | Methods of Improving Therapeutic Efficacy of Mesenchymal Stromal Cells for Treatment of Osteoarthritis | KASAYAN, KATRIEL BARCELLANO | 1634 | §101§103§112 | Non-Final OA | — | Pending | Jan 26, 2024 |
| 18291630 | PHOSPHATE PRODRUGS OF CANNABINOIDS | RAHMANI, NILOOFAR | 1691 | §102§112 | Non-Final OA | — | Pending | Jan 24, 2024 |
| 18580674 | BAK ACTIVATORS, PHARMACEUTICAL COMPOSITIONS, AND USES IN TREATING CANCER | HAVLIN, ROBERT H | 1626 | §102§103§112 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18579142 | T Cell Receptors (TCR) to Human Papillomavirus Proteins, Compositions, and Uses Thereof | GODDARD, LAURA B | — | §101§102§103§112 | Non-Final OA | — | Pending | Jan 12, 2024 |
| 18572536 | 3-Iodopropyl-1,2,3-Triazol-1-yl, 3-Bromopropyl-1,2,3-Triazol-1-yl, and Derivatives for Uses in Labeling | LEWOCZKO, EVAN MICHAEL | 1612 | §103DP | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18542154 | SYSTEMS, APPARATUSES, AND METHODS TO MEASURE ADHESION OF BLOOD CELLS IN MICROFLUIDIC CHANNELS | JARRETT, LORE RAMILLANO | — | §102§103§112 | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18542096 | SYSTEMS AND METHODS TO MEASURE OCCLUSION OF BLOOD CELLS IN MICROFLUIDIC CHANNELS | ORANGE, DAVID BENJAMIN | — | §102§112 | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18527046 | Catheter Retention Device | STIMPERT, PHILIP EARL | 3783 | §102§103§112 | Non-Final OA | — | Pending | Dec 01, 2023 |
| 18564391 | SYSTEMS AND METHODS OF USING NANOMEMBRANE ELECTRONICS | SOLOMON, JOSHUA BRENDON | 3792 | §101§103 | Non-Final OA | 48d | Pending | Nov 27, 2023 |
| 18561673 | JAK Inhibitors for Managing Conditions in Patients with Down's Syndrome or Other Trisomy | LANDSMAN, ROBERT S | — | §112 | Non-Final OA | — | Pending | Nov 16, 2023 |
| 18510060 | Methods of Treating Cancer and Infectious Diseases Using Cell Based Therapies | SINGH, ANOOP KUMAR | 1632 | §103§112DP | Non-Final OA | — | Pending | Nov 15, 2023 |
| 18289868 | ISOLATION AND ANALYSIS OF SINGLE CELLS SECRETING MOLECULES USING HETEROFUNCTIONAL PARTICLES | LUSI, ELLIS FOLLETT | 1677 | §102§112 | Non-Final OA | — | Pending | Nov 07, 2023 |
| 18558874 | NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS, COMBINATIONS AND USES RELATED THERETO | GALSTER, SAMUEL LEONARD | 1693 | §103 | Final Rejection | — | Pending | Nov 03, 2023 |
| 18558026 | CELL POTENCY ASSAYS, PLATFORMS, AND METHODS OF USE | ARMATO JR, DENNIS IGNATIUS | 1651 | §102§112 | Final Rejection | 6d | Pending | Oct 30, 2023 |
| 18285789 | THIONUCLEOSIDES AS ANTIVIRAL AGENTS | LAU, JONATHAN S | 1693 | §103§112 | Non-Final OA | — | Pending | Oct 05, 2023 |
| 18274682 | Rotatable Hip Prosthesis | DUDDEN, TERESA MARIE | 3774 | §112 | Final Rejection | — | Pending | Jul 27, 2023 |
| 18034520 | Modulators of Orphan Nuclear Receptors for Treating Pancreatitis, Glioblastoma, Sarcopenia and Stroke | KUCKLA, ANNA GRACE | 1626 | §103§112 | Non-Final OA | — | Pending | Apr 28, 2023 |
| 18176021 | CIRCULAR RNAS AND THEIR USE IN IMMUNOMODULATION | LEONARD, ARTHUR S | 1631 | §103 | Final Rejection | — | Pending | Feb 28, 2023 |
| 18111350 | RESPONSE-GUIDED HCV THERAPY | CHANDRAKUMAR, NIZAL S | 1625 | §103§112 | Non-Final OA | — | Pending | Feb 17, 2023 |
| 18000865 | DIRECT IN VIVO REPROGRAMMING USING TRANSCRIPTION FACTOR ETV2 GENE FOR ENDOTHELIAL CELL AND VESSEL FORMATION | KIM, TAEYOON | 1631 | §102§103 | Non-Final OA | 49d overdue | Pending | Dec 06, 2022 |
| 17925179 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING A SARS-COV-2 INFECTION | SALVOZA, M FRANCO G | 1672 | §103§112 | Non-Final OA | — | Pending | Nov 14, 2022 |
| 17909844 | Heteromultivalent Spherical Nucleic Acids and Uses in Therapeutic and Diagnostic Applications | CROW, ROBERT THOMAS | 1683 | §103 | Non-Final OA | 36d overdue | Pending | Sep 07, 2022 |
| 17908766 | Radionuclide Tracers of 1-Amino-3,4-Difluorocyclopentane-1-Carboxylic Acid, Derivatives, and Uses Thereof | WESTERBERG, NISSA M | 1618 | §103 | Non-Final OA | 67d overdue | Pending | Sep 01, 2022 |
| 17842433 | CSF-BASED PROGNOSTIC BIOMARKERS IN ALZHEIMER'S DISEASE AND METHODS OF USE THEREOF | FRITCHMAN, REBECCA M | 1758 | §103 | Final Rejection | — | Pending | Jun 16, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial